Literature DB >> 7758167

Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA.

J Du1, P Delafontaine.   

Abstract

Insulin-like growth factor I (IGF I) is an autocrine/paracrine growth factor that is produced in multiple tissues and is essential for normal developmental growth. Its effects are mediated by activation of a membrane-bound tyrosine kinase receptor, IGF IR. On the basis of the partial rat IGF IR alpha-chain cDNA sequence previously reported, we cloned cDNA encoding the full-length rat IGF IR. The deduced amino acid sequence predicts a 1370-amino acid receptor precursor, which includes signal sequence, a 707-amino acid alpha-chain, a 4-Arg cleavage site, and a 629-amino acid beta-chain. Overall, similarity to human IGF IR is 89% and 98% at the nucleotide and amino acid levels, respectively. Antisense IGF IR expression constructs in vectors incorporating Epstein-Barr virus replicative signals and the cytomegalovirus promoter/enhancer or the inducible human metallothionein IIa promoter/enhancer were assembled and stably transfected into cultured rat aortic smooth muscle cells. Clone CA9 (constitutively expressing abundant antisense IGF IR transcripts), clones MA5 and MA7 (expressing antisense IGF IR transcripts inducibly), and clones ME8 and ME10 (expressing vector alone) were characterized. There was a 57% reduction in IGF IR mRNA levels in clone CA9 after confluence compared with clone ME10. This resulted in a 51% decrease in IGF I binding sites in clone CA9, without a change in binding affinity (Kd), and a 55% and 57% reduction in DNA synthesis rates, basally and in response to 10 ng/mL IGF I, respectively. Clones MA5/MA7 similarly showed a 54% reduction in IGF IR number after confluence following exposure to 100 mumol/L ZnSO4 and a 44% and 58% reduction in DNA synthesis, basally and in response to 10 ng/mL IGF I, respectively. Growth curves indicated that proliferation of clone CA9 in the presence of 10% serum was reduced by 60% compared with clone ME10. Thus, cloning of cDNA encoding the full-length rat IGF IR indicates that this receptor is highly conserved. Antisense targeting of this receptor in vascular smooth muscle cells (VSMCs) demonstrates that a decrease in IGF IR density results in marked inhibition of VSMC proliferation. These findings indicate an important role for this ligand-receptor system in regulating VSMC growth. Specifically, they suggest that modulation of VSMC IGF IR density may be an important mechanism whereby growth of these cells is controlled.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758167     DOI: 10.1161/01.res.76.6.963

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  5 in total

1.  Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.

Authors:  Yewei Ma; Liping Zhang; Tao Peng; Jizhong Cheng; Shilpa Taneja; Jiqiang Zhang; Patrice Delafontaine; Jie Du
Journal:  Endocrinology       Date:  2005-12-01       Impact factor: 4.736

2.  Mechanical stretch and intimal hyperplasia: the missing link?

Authors:  Samuel Lee; Richard T Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03       Impact factor: 8.311

3.  G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells.

Authors:  P Delafontaine; A Anwar; H Lou; L Ku
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 4.  Insulin's actions on vascular tissues: Physiological effects and pathophysiological contributions to vascular complications of diabetes.

Authors:  Jialin Fu; Marc Gregory Yu; Qian Li; Kyoungmin Park; George L King
Journal:  Mol Metab       Date:  2021-04-18       Impact factor: 8.568

5.  Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes.

Authors:  Qian Li; Jialin Fu; Yu Xia; Weier Qi; Atsushi Ishikado; Kyoungmin Park; Hisashi Yokomizo; Qian Huang; Weikang Cai; Christian Rask-Madsen; C Ronald Kahn; George L King
Journal:  Nat Commun       Date:  2019-09-27       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.